- Pharmaceuticals
Our Commitment to a Healthier Pakistan
For over 60 years, Bayer has remained committed to contributing to the healthcare landscape in Pakistan. We continue to provide patients and their doctors with access to world class therapies to treat a variety of conditions. Our portfolio in Pakistan focuses on the fields of Women’s Health, Ophthalmology, Cardiology and Stroke Prevention, Oncology and Radiology.
Women’s health – part of Bayer’s DNA
In line with Bayer’s global leadership position in women’s health, we have a comprehensive portfolio of brands for gynecological and reproductive health related conditions, empowering women with choices at every stage of life: from menarche to menopause and beyond. These include long-acting reversible contraceptives (LARC) and short-acting contraceptive options. Additionally, we have therapies for cycle irregularities, androgen excess, heavy menstrual bleeding (HMB), hormone replacement therapy (HRT), dysmenorrhea, post menstrual dysphoric disorder (PMDD), prevention of postmenopausal osteoporosis, and more.
Ophthalmology
Bayer is shaping the future of ophthalmology with an unwavering commitment to reducing the incidence of preventable blindness and helping patients see a better life. We provide innovative therapies for retinal diseases, and engage with healthcare providers across the country to strengthen knowledge-sharing for the benefit of patients. Our vision is clear: to deliver landscape defining treatments that improve outcomes and transform the standard of care for people across Pakistan who are living with serious eye conditions.
Cardiology and Stroke Prevention
Bayer is a global leader in cardiology, advancing a growing portfolio of innovative treatments in cardiovascular diseases with high, unmet medical need. Our cardiology portfolio includes therapies for Stroke Prevention in Atrial Fibrillation (SPAF), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Venous Thromboembolism (VTE) and Hypertension. By offering these life-saving medications, we aim to reduce the risk of severe cardiovascular events and meaningfully improve patient outcomes and quality of life.
Oncology
Bayer is committed to improving the lives of patients affected by cancer through our innovative oncology solution. With our portfolio, we are advancing cancer treatments with the goal of extending survival and managing quality of life for cancer patients we serve.
Radiology
Our Radiology segment provides state-of-the-art diagnostic imaging solutions, empowering healthcare professionals to make precise and targeted diagnoses across a wide spectrum of medical conditions. These advanced tools enhance the ability of healthcare professionals to tailor treatments to each patient's specific needs, ensuring more effective and personalized care.
COR-OTH-PK-0005-2